Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
Mol Cell Biol ; 20(13): 4922-31, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10848617

ABSTRACT

During entry, herpes simplex virus type 1 (HSV-1) releases its capsid and the tegument proteins into the cytosol of a host cell by fusing with the plasma membrane. The capsid is then transported to the nucleus, where it docks at the nuclear pore complexes (NPCs), and the viral genome is rapidly released into the nucleoplasm. In this study, capsid association with NPCs and uncoating of the viral DNA were reconstituted in vitro. Isolated capsids prepared from virus were incubated with cytosol and purified nuclei. They were found to bind to the nuclear pores. Binding could be inhibited by pretreating the nuclei with wheat germ agglutinin, anti-NPC antibodies, or antibodies against importin beta. Furthermore, in the absence of cytosol, purified importin beta was both sufficient and necessary to support efficient capsid binding to nuclei. Up to 60 to 70% of capsids interacting with rat liver nuclei in vitro released their DNA if cytosol and metabolic energy were supplied. Interaction of the capsid with the nuclear pore thus seemed to trigger the release of the viral genome, implying that components of the NPC play an active role in the nuclear events during HSV-1 entry into host cells.


Subject(s)
Capsid/metabolism , Cell Nucleus/ultrastructure , Herpesvirus 1, Human/pathogenicity , Animals , Capsid/drug effects , Capsid/isolation & purification , Capsid/ultrastructure , Cell Nucleus/metabolism , Cell Nucleus/virology , Chlorocebus aethiops , DNA, Viral/metabolism , GTP-Binding Proteins/metabolism , Karyopherins , Nuclear Proteins/metabolism , Rats , Trypsin/pharmacology , Vero Cells/virology , ran GTP-Binding Protein/metabolism
2.
J Immunol ; 164(7): 3600-7, 2000 Apr 01.
Article in English | MEDLINE | ID: mdl-10725716

ABSTRACT

Dendritic cells (DCs) play a critical role as APCs in the induction of the primary immune response. Their capacity for Ag processing and presentation is tightly regulated, controlled by a terminal developmental sequence accompanied by striking changes in morphology, organization, and function. The maturation process, which converts DCs from cells adapted for Ag accumulation to cells adapted for T cell stimulation, remains poorly understood due in part to difficulties in the culture and manipulation of DCs of defined lineages. To address these issues, we have devised conditions for the culture of a single DC type, Langerhans cells (LCs), using CD34+ cells from G-CSF-mobilized patients. Homogenous populations of LCs, replete with abundant immunocytochemically demonstrable Birbeck granules, could be stably maintained as immature DCs for long periods in culture. Unlike other human DC preparations, the LCs remained fully differentiated after cytokine removal. Following exposure to TNF-alpha, LPS, or CD40 ligand, the LCs could be synchronously induced to mature. Depending on the agent used, distinct types of LCs emerged differing in their capacity for T cell stimulation, IL-12 production, intracellular localization of MHC products, and overall morphology. Most interestingly, the expression of different sets of Toll family receptors is induced or down-regulated according to the maturation stimulus provided. These results strongly suggest that different proinflammatory stimuli might drive distinct developmental events.


Subject(s)
Antigens, CD34/biosynthesis , Cell Culture Techniques/methods , Granulocyte Colony-Stimulating Factor/physiology , Langerhans Cells/cytology , Langerhans Cells/immunology , Stem Cells/cytology , Stem Cells/immunology , Adult , Antigens, CD1/biosynthesis , Antigens, Differentiation, T-Lymphocyte , Antigens, Neoplasm , CD40 Ligand , Cell Count , Cell Differentiation/drug effects , Cell Differentiation/immunology , Dendritic Cells/cytology , Dendritic Cells/immunology , Dendritic Cells/metabolism , Hematopoietic Stem Cell Transplantation , Humans , Immunophenotyping , Langerhans Cells/metabolism , Leukapheresis , Ligands , Lipopolysaccharides/pharmacology , Membrane Glycoproteins/biosynthesis , Membrane Glycoproteins/pharmacology , Stem Cells/metabolism , Tumor Necrosis Factor-alpha/pharmacology
3.
EMBO J ; 16(19): 5998-6007, 1997 Oct 01.
Article in English | MEDLINE | ID: mdl-9312057

ABSTRACT

Adenovirus targets its genome to the cell nucleus by a multistep process involving endocytosis, membrane penetration and cytoplasmic transport, and finally imports its DNA into the nucleus. Using an immunochemical and biochemical approach combined with inhibitors of nuclear import, we demonstrate that incoming viral DNA and DNA-associated protein VII enter the nucleus via nuclear pore complexes (NPCs). Depletion of calcium from nuclear envelope and endoplasmic reticulum cisternae by ionophores or thapsigargin blocked DNA and protein VII import into the nucleus, but had no effect on virus targeting to NPCs. Calcium-depleted cells were capable of disassembling incoming virus. In contrast, inhibitors of cytosolic O-linked glycoproteins of the NPC blocked virus attachment to the nuclear envelope, capsid disassembly and also nuclear import of protein VII. The data indicate that NPCs have multiple roles in adenovirus entry into cells: they contain a virus-binding and/or dissociation activity and provide a gateway for the incoming DNA genome into the nucleus.


Subject(s)
Adenoviridae/physiology , DNA, Viral/metabolism , Nuclear Envelope/virology , Viral Structural Proteins/metabolism , Adenoviridae/genetics , Antibodies , Biological Transport/drug effects , Calcium/metabolism , Capsid/metabolism , Cell Nucleus/metabolism , Cell Nucleus/virology , HeLa Cells , Humans , In Situ Hybridization, Fluorescence , Nuclear Envelope/metabolism , Wheat Germ Agglutinins/pharmacology
4.
J Cell Biol ; 136(5): 1007-21, 1997 Mar 10.
Article in English | MEDLINE | ID: mdl-9060466

ABSTRACT

Herpes simplex virus 1 fuses with the plasma membrane of a host cell, and the incoming capsids are efficiently and rapidly transported across the cytosol to the nuclear pore complexes, where the viral DNA genomes are released into the nucleoplasm. Using biochemical assays, immunofluorescence, and immunoelectron microscopy in the presence and absence of microtubule depolymerizing agents, it was shown that the cytosolic capsid transport in Vero cells was mediated by microtubules. Antibody labeling revealed the attachment of dynein, a minus end-directed, microtubule-dependent motor, to the viral capsids. We propose that the incoming capsids bind to microtubules and use dynein to propel them from the cell periphery to the nucleus.


Subject(s)
Capsid/metabolism , Cell Nucleus/virology , Herpesvirus 1, Human/metabolism , Microtubules/physiology , Actin Cytoskeleton/drug effects , Animals , Biological Transport , Capsid/biosynthesis , Capsid Proteins , Chlorocebus aethiops , Cytochalasin D/pharmacology , Cytoplasm/virology , Dyneins/analysis , Immediate-Early Proteins/biosynthesis , Microtubules/drug effects , Nocodazole/pharmacology , Paclitaxel/pharmacology , Vero Cells
SELECTION OF CITATIONS
SEARCH DETAIL